These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34913590)

  • 21. Solitary Hard Palate Langerhans Cell Histiocytosis Demonstrated on PET/CT Scan in an Adult.
    Chen H; Fan Q; Su M
    Clin Nucl Med; 2020 Oct; 45(10):811-812. PubMed ID: 32804762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solitary Adult Rib Langerhans Cell Histiocytosis Evaluated by 18F-FDG PET/CT.
    Wang Q; Yang S; Tang W; Liu H; Chen Y
    Clin Nucl Med; 2021 Sep; 46(9):756-758. PubMed ID: 33795592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET-CT in pediatric Langerhans cell histiocytosis.
    Kaste SC; Rodriguez-Galindo C; McCarville ME; Shulkin BL
    Pediatr Radiol; 2007 Jul; 37(7):615-22. PubMed ID: 17564738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET/CT Imaging for Langerhans Cell Histiocytosis Involving Only Posterior Elements of the Cervical Vertebra.
    Zhang W; Xie H; Su M
    Clin Nucl Med; 2021 Nov; 46(11):e531-e533. PubMed ID: 34606487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive Langerhans cell histiocytosis transformation of T cell acute lymphoblastic leukemia detected on
    Wang J; Song T; Wang J; Ma L; Jiang Y; Kong D; Zhang B; Lu J
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):642-643. PubMed ID: 32504290
    [No Abstract]   [Full Text] [Related]  

  • 26. Pituitary involvement of langerhans cell histiocytosis in an adult unveiled by FDG PET/CT.
    Ju H; Pan Y; Lv J; Mao X; Zhang Y
    Clin Nucl Med; 2015 Jun; 40(6):509-11. PubMed ID: 25546208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary langerhans cell histiocytosis: PET/CT for initial workup and treatment response evaluation.
    Hansen NJ; Hankins JH
    Clin Nucl Med; 2015 Feb; 40(2):153-5. PubMed ID: 24999688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. F-18 FDG PET/CT imaging of solitary liver Langerhans cell histiocytosis: preliminary findings.
    Hu X; Dong A; Lv S; Wang Q; Zhan X; Song X; Wang J
    Ann Nucl Med; 2012 Jun; 26(5):436-9. PubMed ID: 22396242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on: FDG PET-CT in pediatric Langerhans cell histiocytosis: Can all birds be killed with just one stone?
    Buhtoiarov IN
    Pediatr Blood Cancer; 2020 May; 67(5):e28214. PubMed ID: 32037736
    [No Abstract]   [Full Text] [Related]  

  • 31. Langerhans cell histiocytosis of the auditory canal detected by 18F-FDG PET/CT.
    Mueller RJ; Siegel A; Seltzer M; McKnight TA
    Clin Nucl Med; 2012 Sep; 37(9):908-9. PubMed ID: 22889788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ¹⁸F-FDG PET/CT in worsening of Primary Sclerosing Cholangitis concomitant with improved Langerhans Cell Histiocytosis.
    Jain S; Karunanithi S; Singla S; Kumar A; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):386-7. PubMed ID: 25043775
    [No Abstract]   [Full Text] [Related]  

  • 33. FDG-PET/CT in pulmonary and cardiac Langerhans' cell histiocytosis and metastatic non-small cell lung cancer.
    Schreiber J; Waldburg N
    Nucl Med Biol; 2012 Nov; 39(8):1173-4. PubMed ID: 22819194
    [No Abstract]   [Full Text] [Related]  

  • 34. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma.
    Szturz P; Řehák Z; Koukalová R; Adam Z; Krejčí M; Pour L; Zahradová L; Vaníček J; Nebeský T; Hájek R; Mayer J
    Nucl Med Biol; 2012 Apr; 39(3):429-36. PubMed ID: 22172385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
    BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial 18 F-FDG PET/CT Revealing Mixed Histiocytosis in a Pediatric Patient.
    Singh K; Lau L; Wegner EA; Rossleigh MA; Shon IH
    Clin Nucl Med; 2024 Oct; 49(10):e518-e520. PubMed ID: 39150359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.
    Binkovitz LA; Olshefski RS; Adler BH
    Pediatr Radiol; 2003 Sep; 33(9):598-602. PubMed ID: 12879314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.